ArticleClinical case reports2019

Hemolytic anemia after switching from infliximab originator to biosimilar CT-P13 in a patient with inflammatory bowel disease: A case report.

Anne S Strik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.